Thermo Fisher Scientific, a leader in life sciences, has announced a deal to acquire Clario, a company specializing in drug trial data software, for up to $9.4 billion in cash. This significant acquisition marks a major private equity buyout in the pharmaceutical technology sector.
The American Customer Satisfaction Index read 76.1 in August 2026, the same score it held in 2015, so United States customer expectations have held flat for eleven years while complaints hit records and the variable that actually moved was tolerance.
Read More
TLDR: Regulated-industry marketers who build neuromarketing capabilities at pre-launch stage convert compliance...
Read More